Product NDC: | 0173-0260 |
Proprietary Name: | LANOXIN |
Non Proprietary Name: | digoxin |
Active Ingredient(s): | 250 ug/mL & nbsp; digoxin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0260 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA009330 |
Marketing Category: | NDA |
Start Marketing Date: | 19851001 |
Package NDC: | 0173-0260-10 |
Package Description: | 10 AMPULE in 1 BOX (0173-0260-10) > 2 mL in 1 AMPULE |
NDC Code | 0173-0260-10 |
Proprietary Name | LANOXIN |
Package Description | 10 AMPULE in 1 BOX (0173-0260-10) > 2 mL in 1 AMPULE |
Product NDC | 0173-0260 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | digoxin |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19851001 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | DIGOXIN |
Strength Number | 250 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |